PharmBrief | Новости фармации

📈 Analytical overview of Telegram channel PharmBrief | Новости фармации

Channel PharmBrief | Новости фармации (@pharmbrief) in the Russian language segment is an active participant. Currently, the community unites 10 454 subscribers, ranking 2 616 in the Medicine category and 61 000 in the Russia region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 10 454 subscribers.

According to the latest data from 08 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 315 over the last 30 days and by 19 over the last 24 hours, overall reach remains high.

• Verification status: Not verified
• Engagement rate (ER): The average audience engagement rate is 19.23%. Within the first 24 hours after publication, content typically collects 13.02% reactions from the total number of subscribers.
• Post reach: On average, each post receives 2 010 views. Within the first day, a publication typically gains 1 361 views.
• Reactions and interaction: The audience actively supports content: the average number of reactions per post is 20.
• Thematic interests: Content is focused on key topics such as строка, вакцина, fda, минздрав, акрихин.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
“Фарма одной строкой. Новости фармации и фармацевтики. Мы в Дзен - dzen.ru/pharmbrief Совместный проект t.me/PharmJokes и t.me/scitramon По рекламе писать в каналы по ссылкам выше”

Thanks to the high frequency of updates (latest data received on 09 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.